SOCS5 and B-cell chronic lymphocytic leukemia: Treatment of monocytes from healthy donors with IL-10, which activates STAT3, led to similar signaling events as that observed in patients, including enhanced expression of SOCS5 and inhibition of STAT6 activation, resulting in defective Mo-DC differentiation analogous to that seen in CLL-derived Mo-DCs.